Medicago USA Inc.
Medicago develops vaccines based on proprietary manufacturing technologies and virus-like particles. The vaccines are manufactured using a transient protein expression system in Nicotiana benthamiana, a close relative of tobacco.
Employment range in NC
Primary site activity
Products on market
plant-based Proficia™ technology, a robust vaccine and antibody production system based on transient protein expression in plant leaves
Products under development
Seasonal and Pandemic influenza vaccines, CoVID 19 vaccine, and other vaccines and biosimilars